TA
KPTI icon

Teachers Advisors’s Karyopharm Therapeutics KPTI Stock Holding History

Teachers Advisors’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.64M Buy
30,095
+7,364
+32% +$816K ﹤0.01% 1805
2018
Q4 		$3.19M Buy
22,731
+232
+1% +$39.1K ﹤0.01% 1564
2018
Q3 		$5.75M Buy
22,499
+320
+1% +$88.5K 0.01% 1372
2018
Q2 		$5.65M Sell
22,179
-6,783
-23% -$1.68M 0.01% 1358
2018
Q1 		$5.83M Sell
28,962
-11
-0% -$2.19K 0.01% 1265
2017
Q4 		$4.17M Buy
28,973
+206
+0.7% +$33.1K 0.01% 1441
2017
Q3 		$4.74M Buy
28,767
+10
+0% +$1.43K 0.01% 1367
2017
Q2 		$3.9M Buy
28,757
+719
+3% +$106K 0.01% 1458
2017
Q1 		$5.4M Buy
28,038
+25,276
+915% +$4.06M 0.01% 1265
2016
Q4 		$389K Buy
2,762
+361
+15% +$48.8K ﹤0.01% 2664
2016
Q3 		$350K Hold
2,401
– – ﹤0.01% 2652
2016
Q2 		$242K Sell
2,401
-34
-1% -$4.42K ﹤0.01% 2796
2016
Q1 		$326K Hold
2,435
– – ﹤0.01% 2568
2015
Q4 		$484K Buy
2,435
+187
+8% +$40.5K ﹤0.01% 2429
2015
Q3 		$355K Sell
2,248
-3,508
-61% -$938K ﹤0.01% 2581
2015
Q2 		$2.35M Buy
5,756
+842
+17% +$364K ﹤0.01% 1577
2015
Q1 		$2.26M Buy
4,914
+238
+5% +$103K ﹤0.01% 1578
2014
Q4 		$2.63M Sell
4,676
-6
-0.1% -$3.41K 0.01% 1450
2014
Q3 		$2.45M Buy
4,682
+380
+9% +$214K ﹤0.01% 1467
2014
Q2 		$3M Buy
4,302
+3,554
+475% +$1.65M 0.01% 1367
2014
Q1 		$346K Buy
748
+12
+2% +$6.08K ﹤0.01% 2595
2013
Q4 		$253K Buy
+736
New +$203K ﹤0.01% 2746

Other funds holding KPTI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Teachers Advisors's KPTI Position: Q1 2019 in Review

Teachers Advisors increased its Karyopharm Therapeutics (KPTI) stake by 32% in Q1 2019, buying an estimated $816K and bringing the position to 30,095 shares worth $2.64M. The position accounts for ﹤0.01% of the portfolio, ranked #1805.

Teachers Advisors first reported a position in KPTI in Q4 2013 and has held it in 22 quarters since. The position peaked at $5.83M in Q1 2018. 108 funds tracked by Wall St. Rank hold KPTI as of Q1 2019.

  • Teachers Advisors held 30,095 shares of Karyopharm Therapeutics worth $2.64M as of Q1 2019.
  • Teachers Advisors bought 7,364 Karyopharm Therapeutics shares in Q1 2019, an estimated $816K.
  • Karyopharm Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #1805 holding.
  • Teachers Advisors first reported a position in Karyopharm Therapeutics in Q4 2013 and has held it in 22 quarters since.
  • Teachers Advisors's Karyopharm Therapeutics position peaked at $5.83M in Q1 2018.
  • 108 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.